Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells.
暂无分享,去创建一个
M. Horinaka | Toshiyuki Sakai | M. Mutoh | H. Ono | S. Yasuda | Y. Iizumi | Hideki Ishikawa | Keiko Taniguchi | Hideki Takakura | E. Nishimoto | Ayaka Imai | Y. Aono
[1] H. Kashida,et al. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial. , 2021, The lancet. Gastroenterology & hepatology.
[2] N. Sims,et al. Rothmund-Thomson Syndrome-Like RECQL4 Truncating Mutations Cause a Haploinsufficient Low-Bone-Mass Phenotype in Mice , 2020, Molecular and Cellular Biology.
[3] Z. Nasr,et al. Ribosomal protein S3 selectively affects colon cancer growth by modulating the levels of p53 and lactate dehydrogenase , 2020, Molecular Biology Reports.
[4] P. Moayyedi,et al. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial , 2018, The Lancet.
[5] Ji Ma,et al. The anti-tumor effect of aspirin: What we know and what we expect. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] L. Stark,et al. Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus , 2017, Biomedicines.
[7] T. Hsieh,et al. Ribosomal Protein S3 Negatively Regulates Unwinding Activity of RecQ-like Helicase 4 through Their Physical Interaction* , 2017, The Journal of Biological Chemistry.
[8] W. Hua,et al. Over-Expression of RPS3 Promotes Acute Lymphoblastic Leukemia Growth and Progress By Down-Regulating COX-2 through NF-κb Pathway , 2016 .
[9] W. Guo,et al. RPS3 regulates melanoma cell growth and apoptosis by targeting Cyto C/Ca2+/MICU1 dependent mitochondrial signaling , 2015, Oncotarget.
[10] J. Mathers,et al. Chemoprevention in Lynch syndrome , 2013, Familial Cancer.
[11] K. Wakabayashi,et al. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial , 2013, Cancer medicine.
[12] P. Rothwell,et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials , 2012, The Lancet.
[13] S. Snyder,et al. Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. , 2012, Molecular cell.
[14] J. Kim,et al. Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest , 2011, Oncogene.
[15] S. Edge,et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype , 2011, Cancer Causes & Control.
[16] A. Algra,et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.
[17] L. Mayo,et al. Ribosomal protein S3: A multi-functional protein that interacts with both p53 and MDM2 through its KH domain. , 2009, DNA repair.
[18] H. Ishikawa,et al. Chemoprevention of colorectal cancer in Japan: a brief introduction to current clinical trials , 2009, Journal of Gastroenterology.
[19] Jian Kuang,et al. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities , 2005, Oncogene.
[20] G. Beck,et al. A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.
[21] J. Roth,et al. Overexpression of the wild-type p53 gene inhibits NF-κB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells , 2000, Oncogene.
[22] R. Gaynor,et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.
[23] C. Rock,et al. Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. , 1997, Journal of the National Cancer Institute.
[24] R. Fellous,et al. Implication of Mammalian Ribosomal Protein S3 in the Processing of DNA Damage (*) , 1995, The Journal of Biological Chemistry.
[25] M. Thun,et al. Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.
[26] I. Wool,et al. Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein , 1991, Molecular and cellular biology.
[27] R. Schoen,et al. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. , 1989, The American journal of medicine.